A Cost-Effectiveness Study of Gaps In Substance Abuse Treatment Services In Nebraska: Prepared For The CPACS Methamphetamine Treatment Facility Feasibility Study by Piper, R. K. & Deichert, Jerry
University of Nebraska at Omaha 
DigitalCommons@UNO 
Publications since 2000 Center for Public Affairs Research 
4-30-2006 
A Cost-Effectiveness Study of Gaps In Substance Abuse 
Treatment Services In Nebraska: Prepared For The CPACS 
Methamphetamine Treatment Facility Feasibility Study 
R. K. Piper 
Jerry Deichert 
Follow this and additional works at: https://digitalcommons.unomaha.edu/cparpublications 
 Part of the Public Affairs Commons 
 
 
 
 
 
 
 
 
 
 
A COST-EFFECTIVENESS STUDY OF GAPS IN SUBSTANCE ABUSE 
TREATMENT SERVICES IN NEBRASKA 
4/30/06 
 
 
 
 
 
 
 
 
 
 
 
Prepared for the CPACS Methamphetamine Treatment Facility Feasibility Study 
 
 
 
 
 
 
 
 
 
 
 
By  
R.K. Piper 
Jerry Diechert 
Center for Public Affairs Research 
 
 
 
 
 
 
 2 
INTRODUCTION 
 
 This internal report has been prepared as part of the larger Methamphetamine 
Treatment Facility Feasibility Study conducted by the College of Public Affairs and 
Community Services for the Nebraska State Legislature.  The major purposes of this 
report are as follows:  1) to integrate previously submitted working findings and tables 
into a single “stand-alone” document and 2) to provide an overview and context for the 
findings that will be useful to technical writers, faculty, staff and graduate assistants who 
are responsible for preparing the final report for the legislature. 
 
Methodology and Research Questions 
 
 This cost study has been guided from the outset by a series of research questions 
developed to systematically identify existing gaps in methamphetamine/amphetamine-
related treatment services in Nebraska and to provide cost estimates for programs and 
facilities to meet identified needs.  Table A. summarizes the major research questions, as 
well as the data sources and published reports consulted in their investigation. 
 
Table A. 
Methamphetamine Treatment-Facility Cost Research Questions and Data 
Sources/Published Reports Consulted 
 
Major Study Areas Research Questions Published/Internal 
Reports & Data Sources 
(National/States) 
Substance- Abuse 
Treatment Needs 
and Costs 
1.  What is the total prevalence 
(population) of illicit-drug, stimulant-
related and meth-amphetamine related 
substance abusers  in NE? 
 
  a.   Of these, how many are 
receiving treatment (met demand)? 
 
  b.   How many need but are not in 
treatment? 
 
  c.  How many want or would seek 
treatment if it was available (unmet 
demand)? 
  
   
2.  What are the average costs for 
drug treatment by level of treatment 
(e.g., for residential and outpatient 
levels)? 
  
What are the estimated treatment 
costs to meet the unmet demand of 
those who are not receiving 
treatment, but want or would seek 
treatment? 
 
1.  “State Estimates of Substance Use from the 2002-2003 
National Suverys on Drug Use and Health,” SAMHSA 
(2004). 
 
“Substance Abuse Treatment Admissions by State and 
Primary Substance of Abuse,” SAMHSA (2003). 
 
“Analysis of Substance Abuse Prevalence, Treatment 
Resources and Gaps in Colorado,” State of Colorado 
(2002). 
 
 
 
 
 
 
2.  “DATStats:  Results from 85 studies using the Drug 
Abuse Treatment Cost Program Analysis (DATCAP), by 
M.C. Roebuck et al, Journal of Drug Abuse Treatment 
(2003). 
 
“State Estimates of Substance Use from the 2002-2003 
National Suverys on Drug Use and Health,” SAMHSA 
(2004).  
 
 
Substance-Abuse 
Treatment Facility 
Costs 
1.  What types and how many 
facilities currently provide substance 
abuse treatment in NE? 
 
 
1.  “National Survey of Substance Abuse Treatment 
Services (N-SSATS) State Profile Nebraska,”  SAMHSA 
(2003). 
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Substance-Abuse 
Treatment Facility 
Costs (continued)  
a. What are the fixed costs for these 
types of treatment facilities? 
 
b.  What are the combined fixed and 
variable (treatment program) costs 
for each  type?   
a.  (Pending master budgets, audited facility, performance 
reports to be provided by the State of  Nebraska.) 
 
b. “DATStats:  Results from 85 studies using the Drug 
Abuse Treatment Cost Program Analysis (DATCAP), by 
M.C. Roebuck et al, Journal of Drug Abuse Treatment 
(2003). 
Impacts of 
Substance-Abuse 
Treatment on State 
Budgets 
1.  What portion of the Nebraska 
State Budget is currently devoted to 
dealing with the impacts of substance 
abuse? 
 
  a. What are the major areas of state 
spending that are most impacted by 
substance abuse? 
 
  b. What portion of state spending is 
devoted to substance abuse treatment 
and prevention? 
 
c. How does this compare to 
surrounding states? 
 
d. How does this compare to the 
national average? 
 
1.  “Shoveling Up:  The Impact of Substance Abuse on 
State Budgets,” National Center on Addiction and 
Substance Abuse at Columbia (CASA), (2001). 
 
“Nebraska Department of Correctional Services (DCS) 
FY-2004 Annual Report and Statistical Summary.” 
 
 
Summary and Cost Estimation Models Based on Findings 
 
 Based on the information collected and analyzed, estimated gaps in substance 
abuse treatment services in Nebraska are illustrated by type of drug in four concentric 
circles in Figures 1-3.  Cost estimates if the total unmet demand were met at any 
single level of treatment are also shown in the figures for five of the six levels of 
treatment identified in the report.  Additional estimates for alternative combinations of 
residential and outpatient treatment are provided in Section V. of the report. 
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Figure 1. 
Gaps in Substance Abuse Treatment Services—Any Illicit Drug-Related 
 
Total unmet demand   2,981 persons 
 
Estimated cost to meet unmet demand at any single level of treatment 
Residential   $12.8 million 
Therapeutic community $25.6 million 
Standard outpatient  $  2.9 million 
Intensive outpatient  $  6.0 million 
Drug court   $  4.7 million 
 
Total prevalence 
Not in treatment 
 
In treatment 
(Met demand) 
Would seek 
treatment 
(Unmet 
demand) 
2,981 
5,678 
59,617 
65,295 
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Figure 2. 
Gaps in Substance Abuse Treatment Services—Stimulant-Related 
 
Total unmet demand   1,985 persons 
 
Estimated cost to meet unmet demand at any single level of treatment 
Residential   $12.8 million 
Therapeutic community $25.6 million 
Standard outpatient  $  2.9 million 
Intensive outpatient  $  6.0 million 
Drug court   $  4.7 million 
Total prevalence 
Not in treatment 
 
In treatment 
(Met demand) 
Would seek 
treatment 
(Unmet 
demand) 
1,985 
3,781 
39,705 
43,486 
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Figure 3. 
Gaps in Substance Abuse Treatment Services—Meth-/Amphetamine-Related 
 
Total unmet demand   1,359 persons 
 
Estimated cost to meet unmet demand at any single level of treatment 
Residential   $12.8 million 
Therapeutic community $25.6 million 
Standard outpatient  $  2.9 million 
Intensive outpatient  $  6.0 million 
Drug court   $  4.7 million 
 
Total prevalence 
Not in treatment 
 
In treatment 
(Met demand) 
Would seek 
treatment 
(Unmet 
demand) 
1,359 
2,589 
27,185 
29,774 
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Uses and Refinement of the Gaps in Treatment and Cost Estimate Model  
 
 The findings in the report are presented as a model to estimate gaps in substance 
abuse treatment services (especially related to meth-and amphetamine abuse) in Nebraska 
and the variable (program) and fixed (facilty) costs to address them.  When more- 
complete and program-specific data becomes available from the Nebraska Departments 
of Health and Human Services (N-HHS) and Correctional Services (DCS) and other 
sources, they can be incorporated into the model.  Regardless of whether additional data 
becomes available, the findings in this report and the model can be used by policy-
makers and program administrators to better understand the needs for additional drug 
treatment services and the costs of providing them. 
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MAJOR RESEARCH FINDINGS 
 
 The major research findings in this report are presented in the order they were 
developed in five areas: 
 
 I. Impacts of Substance Abuse on the Nebraska State Budget;  
 II. Treatment Admissions in Nebraska; 
 III. Levels of Treatment/Costs at Nebraska Department of Corrections Facilities; 
 IV. Prevalence of Substance Dependence/Abuse; Users Needing but Not 
        Receiving Treatment; Unmet Treatment Demand in Nebraska; 
  V. Cost Estimates for Unmet Treatment Demand in Nebraska. 
 
  As requested, key findings have been presented as highlighted bullets and include 
summary tables and in-depth working tables (all tables are numbered 1-25 and 
working tables in Excel format are identified by file name: for example, State 
Spending (NE).xls).  
 
I.  IMPACTS OF SUBSTANCE ABUSE ON THE NEBRASKA STATE BUDGET 
  
 A review and analysis of Nebraska state budget information conducted in 2001 by 
the National Center on Addiction and Substance Abuse at Columbia University (CASA)1 
reveals the following key findings (which do not include any Federal or local spending): 
 
• The state government of Nebraska spent about $291 million or 8.2% of the 
entire annual state budget ($3.5 billion) dealing with the impacts, 
regulation/compliance functions and problems of substance abuse.  Of this 
amount, only about $9 million or .3% was spent by the state on substance 
abuse treatment, prevention and research.  (See Tables 1-7 for Nebraska and 
six surrounding states [State Spending (NE).xls]).   
 
• For every dollar the state of Nebraska spends on substance abuse: 
 
o 91 cents goes to pay for the burden of this problem on public 
programs in the affected areas of criminal justice, 
elementary/secondary education, health, child/family assistance, 
mental health/developmental disability, public safety and the state 
workforce.   
 
o Only 3.1 cents goes to fund prevention, treatment and research 
programs aimed at reducing the incidence and consequences of 
substance abuse. 
 
                                                 
1 “Shoveling Up:  The Impact of Substance Abuse on State Budgets,” by the National Center on Addiction 
and Substance Abuse at Columbia (2001) is based on detailed budget data for 1998 submitted by Nebraska 
and 46 other state budget officials. 
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o  The remaining 5.8 cents goes for regulation/compliance of alcohol and 
tobacco licensing, control and collection of taxes (compared to a national 
average of only .5 cents).2 
 
(Table 1. shows the total spending in each category in Nebraska, the 
amount and percentage related to substance abuse and the per capita 
amount spent for each person in the state). 
 
• Even though state spending on substance abuse cannot be disaggregated by 
type of drug (e.g., methamphetamines), nationwide results show that 78.2% is 
related to a combination of both illicit drugs and alcohol, while only 11.3% 
could be attributed to alcohol only, 9.1% to tobacco only and 1.4% to illicit 
drugs only. 
 
Based on these findings, the estimated amount of state spending in Nebraska 
linked to abuse of illicit drugs (in combination with and without alcohol) is 
about $232 million (79.6% of $291 million).  Of this amount, approximately 
$225 million goes toward cleaning up the wreckage of illicit drug abuse, 
while only about $7 million is applied to illicit drug prevention and 
treatment.3 
 
II. TREATMENT OF METHAMPHETAMINE, AMPHETAMINE AND OTHER  
STIMULANT ABUSE (NE) 
 
 A review and analysis of 2003 SAMSHA substance abuse treatment admissions 
data for Nebraska reveals the following key findings: 
 
• There were a total of 10,609 admissions for substance abuse treatment; of these, 
4,320 were for alcohol only treatment, while 6,289 (64.4%) were for primary 
substances other than alcohol or alcohol as a primary substance in 
combination with a secondary illicit drug.  (See Table 8 [Substance Abuse 
Admissions NE.xls] for a complete breakdown of treatment admissions in 
Nebraska by primary substance). 
 
• Of these 6,289 non-alcohol only admissions, 4,188 (66.6%) were linked to 
methamphetamines, amphetamines or other stimulants;4 and after 
                                                 
2 This proportion, amounting to .5% of the state budget, is the highest of all reporting states, matched only 
by Alabama and Washington. 
 
3 As all regulation and compliance substance abuse spending is alcohol and tobacco only, the breakdown of 
the $232 million illicit-drug (in combination with and without alcohol) spending estimate is based on the 
total substance abuse spending ratio of  97:3 affected-program spending to treatment, prevention and 
research spending. 
4 This total includes estimates of the number of “alcohol w/secondary drug” and “other/unknown” 
classifications which were stimulant-related (cocaine, amphetamines and other stimulants).  Alcohol 
w/secondary drug estimates were based on the proportion of primary drug admissions which were 
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eliminating primary and secondary cocaine and other stimulant abusers from this 
population, 2,869 (45.6%) were linked to methamphetamines or 
amphetamines.  (Table 9 [Substance Abuse Admissions NE.xls] shows the 
percentages of admissions linked to methamphetamines and other stimulants in 
Nebraska and the six surrounding states).   
 
• Altogether, the 2,869 admissions linked to methamphetamines and 
amphetamines comprise 27.0% of admissions for substance abuse treatment 
(alcohol only + non-alcohol only) in Nebraska.    
 
 
III. LEVELS OF TREATMENT/COSTS AT NEBRASKA DEPARTMENT OF  
CORRECTIONS FACILITIES 
 
 A review of sections of the 2004 Nebraska Department of Correctional Services 
(DCS) annual report related to substance abuse programming and treatment services 
reveals the following: 
 
• The DCS provides four general levels of care:  Residential, Non-Residential, 
Assessment and Evaluation and Emergency.  Table 10. shows DCS facilities that 
offer services at the residential, non-residential and assessment/evaluation levels 
and the annual costs per inmate at each facility. 
 
 
Table 10. 
Nebraska Department of Correctional Services Substance Abuse Levels of Care and 
Costs by Facility 
 
Level of Care NE DCS Facility NE DCS Substance 
Abuse Program 
Total Annual Cost 
per Inmate  
Long-Term 
Residential and 
Residential 
 
1. Nebraska State Penitentiary 
    (100 minimum custody    
males at RTC) 
 
 
 
2. Omaha Correctional Center 
    (72 minimum custody males 
at SAU) 
 
3. Tecumseh State   
Correctional Institution     
(32 minimum custody males 
at SAU) 
 
4. Nebraska Correctional  
Center for Women 
   (28 minimum custody  
females at SAU) 
 
1. Residential Treatment 
Community (10 months) 
    
    Parole Violator  Program 
      (90-120 days intensive) 
 
2. Substance Abuse Unit  
      (10 months) 
 
 
3. Substance Abuse Unit          
(10 months) 
 
 
 
4. Substance Abuse Unit 
      (10 months) 
      
    Parole Violator Program 
      (90-120 days intensive) 
 
1.  $27,834 
 
 
 
 
 
2.  $23,389 
 
 
 
3.  $30,923 
 
 
 
 
4.  $27,423 
                                                                                                                                                 
stimulant-related (70.5%), while a somewhat more conservative estimate of 50% stimulant-related was 
used for “other/unknown” classifications.  
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Non-Residential 
 
 
 
 
 
 
 
 
Non-Residential 
(continued) 
 
 
1. Nebraska State Penitentiary 
 
 
2. Omaha Correctional Center 
 
 
3. Tecumseh State   
Correctional Institution      
 
4. Nebraska Correctional 
Center for Women 
 
 
5. McCook Work Ethic Camp  
 
 
6. Community Corrections 
Center-Lincoln 
 
7. Community Corrections 
Center-Omaha 
 
8. Lincoln Correctional Center 
 
 
9. Nebraska Correctional 
Youth Facility    
 
1. Education, Intensive 
Outpatient, Aftercare 
 
2. Education, Intensive  
Outpatient, Aftercare 
 
3. Education, Intensive 
Outpatient, Aftercare 
 
4. Intensive Outpatient, 
Aftercare 
 
 
5. Education, Intensive 
Outpatient 
 
6. Education, Outpatient, 
Aftercare 
 
7. Education, Outpatient, 
Aftercare 
 
8. Education, Intensive 
Outpatient, Aftercare 
 
9. Education, Intensive 
Outpatient, Aftercare 
 
1.  n/a 
 
 
2.  n/a 
 
 
3.  n/a 
 
 
4.  n/a 
 
 
 
5.  $15,948 (based on number 
of annual admissions) 
 
6.  $15,996 
 
 
7.  $14,705 
 
 
8.  $32,123 
 
 
9.  $68,275 
Evaluation and 
Assessment 
 
1.  Diagnostic and Evaluation 
Center 
 
 
2. Nebraska Correctional  
Center for Women 
 
 
3. Nebraska Correctional 
Youth Facility    
 
1. Diagnosis, Evaluation,   
Assessment, Classification 
and Facility Assignment 
 
2. Diagnosis, Evaluation,   
Assessment, Classification 
and Facility Assignment 
 
3. Diagnosis, Evaluation,   
Assessment, Classification 
and Facility Assignment   
 
1.  $30,977 
 
 
 
2.  n/a 
 
 
 
3.  n/a 
 
 
 
IV. LEVELS OF SUBSTANCE DEPENDENCE/ABUSE; USERS NEEDING BUT 
NOT RECEIVING TREATMENT; UNMET TREATMENT DEMAND (NE). 
 
 A review and analysis of the SAMHSA report “State Estimates of Substance Use 
from the 2002-2003 National Surveys on Drug Use and Health”5 reveals the following 
key findings: 
 
Substance Abuse and Dependence 
 
• A total of 65,295 persons 12 years of age and older (4.6% of that population) 
were estimated to be dependent on or abused illicit drugs in Nebraska in 
2003.6  (Tables 11-19 [Drug Dependence-Abuse Estimates.xls] show the 
estimated ranges of drug dependence and abuse, dependence and persons 
                                                 
5 This SAMHSA report presents state estimates on substance use based on the combined findings of the 
2002 and 2003 National Surveys on Drug Use and Health (NSDUHs), formerly called the National 
Household Survey on Drug Abuse (NHSDA). 
6 This estimate uses 2002-2003 survey results rates applied to 2000 U.S. Census data.  
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needing but not receiving treatment in Nebraska and selected counties (Adams, 
Douglas, Lancaster, Madison, Red Willow and Scotts Bluff). 
 
• When grouped by age, 15,197 were between the ages of 17-25; 22,416 were 18-
25; and 27,638 were 26 or older. 
 
 [The estimate of 65,295 persons is shown as Alternative Estimate B. in table 11.  
Base Estimate A. (40,312) is based on the NSDUH surveys findings that showed 
2.84% of the population aged 12 years and over reported drug dependence or 
abuse in the past 12 months.  Alternative Estimate C. (89,425) is based on a 
model used by the State of Colorado which increased the NSDUH findings in that 
state by 125% (to 7.2%) by factoring in additional state survey data, estimates of 
residents without phones, the homeless, recently incarcerated prisoners, 
adolescents in juvenile corrections facilities, etc.  Alternative Estimate B. is a 
mid-point estimate (not exact due to rounding) between estimates A. and B.] 
 
o Of these, 43,486 (66.6% based on SAMHSA admissions data)7 were 
estimated to be dependent on or abused stimulant-related illicit drugs 
and 29,774 (45.6%) were methamphetamine or amphetamine 
dependent or abusers.  (See Table 20 for age group estimates 
[Dependence-Abuse Cohorts.xls]). 
 
Persons Needing But Not Receiving Treatment 
 
• A total of 59,617 persons 12 and over (4.2%) needed but did not receive 
treatment for an illicit drug use problem in 2003.8  (Table 21 summarizes the 
levels of drug dependence, drug dependence or abuse and numbers of persons 
needing but not receiving treatment in Nebraska and selected counties.) 
 
• When grouped by age, 13,584 were between the ages of 12-17; 19,822 were 18-
25; and 26,211 were 26 or older. 
 
 [The difference between the estimated numbers of persons 12 years of age and 
older in Nebraska who were dependent on or abused any illicit drug (65,295) and 
the number who needed but did not receive treatment during the past 12 months 
(59,617) is 5,678 (based on the National Surveys on Drug Use and Health 
findings).  As shown in Section II., SAMHSA treatment admissions data shows 
that there were 6,289 admissions linked to illicit drugs in Nebraska in 2003.9  
                                                 
7 NSDUH survey findings are further refined by using SAMSHA treatment admissions data for Nebraska 
including estimates of the proportions of   “alcohol w/secondary drug” and “other/unknown” classifications 
that were stimulant- and methamphetamine/amphetamine-related (see Section II., footnote 4). 
8 Persons “needing treatment” are defined as those who are classified as either drug dependent or abusers.  
The status of these are based on the criteria specified in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) (American Psychiatric Association, 1994), indicators of which are included in the 
survey questions.  Those “not receiving treatment” did not receive any during the past 12 months. 
9 Treatment admissions may include multiple admissions for the same person. 
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These very similar findings using two separate data sources support the validity of 
the estimates.] 
             
o Of these, 39,705 stimulant-related (66.6% based on SAMHSA 
admissions data) and 27,185 (45.6%) methamphetamine or 
amphetamine-related problem users needed but did not receive 
treatment.  (See Table 22 for age group estimates [Treatment Needs Age 
Cohorts.xls]). 
 
Table 20. 
Substance Dependence/Abuse and Users Needing But Not Receiving Treatment in 
Nebraska and Selected Counties (2003) 
STATE/Counties       
/(Major City) 
Total 2000 
Population 
 
(Persons 12 yrs. 
and over) 
Drug 
Dependence 
 
(Persons in Past 
Year) 
Drug 
Dependence  
Or Abuse 
(Persons in Past 
Year) 
User Needing/ 
Not Receiving 
Treatment 
(Persons in Past Year) 
 (N) (N)        (%) (N)        (%) (N)        (%) 
NEBRASKA 1,419,450    
     Any Illicit Drug  44,395 (3.1) 65,295 (4.6) 59,617  (4.2) 
      Stimulant-Related Drug  29,306 (2.1) 43,486 (3.1) 39,705  (2.8) 
Meth/Amphetamine- 
Related 
 20,065 (1.4) 29,774 (2.1) 27,185  (1.9) 
Douglas (Omaha) 381,229    
     Any Illicit Drug  11,818 (3.1) 17,537 (4.6) 16,012  (4.2) 
      Stimulant-Related Drug    7,871 (2.1) 11,679 (3.1) 10,664  (2.8) 
Meth/Amphetamine- 
Related 
   5,389 (1.4)   7,997 (2.1)   7,301  (1.9) 
Lancaster (Lincoln) 210,953    
     Any Illicit Drug    6,540 (3.1)   9,704 (4.6)   8,860  (4.2) 
      Stimulant-Related Drug    4,355 (2.1)   6,463 (3.1)   5,901  (2.8) 
Meth/Amphetamine- 
Related 
   2,982 (1.4)   4,425 (2.1)   4,040  (1.9) 
Madison (Norfolk) 29,209    
     Any Illicit Drug      905 (3.1)  1,344 (4.6)  1,227  (4.2) 
      Stimulant-Related Drug      603 (2.1)     895 (3.1)     817  (2.8) 
Meth/Amphetamine- 
Related 
     413 (1.4)     613 (2.1)     559  (1.9) 
Adams (Hastings) 26,165    
     Any Illicit Drug      811 (3.1)  1,204 (4.6)  1,099  (4.2) 
      Stimulant-Related Drug      540 (2.1)     802 (3.1)     732  (2.8) 
Meth/Amphetamine- 
Related 
     370 (1.4)     549 (2.1)     501  (1.9) 
Red Willow (McCook) 9,646    
     Any Illicit Drug      299 (3.1)     444 (4.6)    405  (4.2) 
      Stimulant-Related Drug      199 (2.1)     296 (3.1)    270  (2.8) 
Meth/Amphetamine 
Related 
     136 (1.4)     202 (2.1)    185  (1.9) 
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Scotts Bluff (Scottsbluff) 30,790    
     Any Illicit Drug     954 (3.1)   1,416 (4.6)  1,293 (4.2) 
      Stimulant-Related Drug     636 (2.1)      943 (3.1)     861 (2.8) 
Meth/Amphetamine 
Related 
    435 (1.4)      646 (2.1)     590 (1.9) 
 
 
Unmet Demand for Treatment 
 
• Of the 59,617 persons who needed but did not receive treatment, there is an 
estimated unmet treatment demand in Nebraska of 2,981 illicit drug, 1,985 
stimulant-related and 1,359 methamphetamine- or amphetamine-related 
problem users. 10  
  
Unmet treatment demand refers to those persons who are drug dependent or 
abusers that “needed but did not receive treatment” and also “wanted or would 
seek” treatment if it was available.  (Table 23 shows the unmet treatment demand 
estimates for Nebraska by age group). 
 
Table 23. 
Unmet Treatment Demand Estimates in Nebraska by Age Group (2003) 
 
 Population 
(12+) 
Age 12-17 Age 18-25 26 or Older 
     
Any Illicit Drug 2,981 679 991 1,311 
     
Stimulant-Related 1,985 452 660 873 
     
Meth/Amphetamine-
Related 
1,359 310 452 598 
 
 
V. COST ESTIMATES FOR UNMET TREATMENT DEMAND (NE). 
 
 A review and application of the cost findings in the study, “Results from 85 
studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP),” by M.C. 
Roebuck and other economists supported by the National Institute on Drug Abuse 
(NIDA) reveals the following key findings: 
 
                                                 
10 As with the substance abuse/dependence estimates, the extent to which models used in other states 
accurately reflect conditions in Nebraska is uncertain (despite the cross-validity evidence cited above).  A 
State of Colorado model (see “Analysis of Substance Abuse Prevalence, Treatment Resources and 
Treatment Gaps in Colorado,” by Bruce Mendelson, 2002) used integrated survey findings to determine 
that 2.7% of problem users who did not receive treatment, wanted or would seek treatment if it was 
available.  To estimate unmet treatment demand in Nebraska we use an alternative estimation rate of 5.0%.      
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Residential and Outpatient Treatment Costs 
 
• The estimated costs of providing treatment to meet the unmet demand in 
Nebraska (those who did not receive, but wanted or would seek treatment if it was 
available) varies widely according to the level of treatment or program type.  
(Table 24. shows the estimated costs to meet the aggregate unmet demand11 by 
type of drug and various alternative levels of residential and outpatient 
treatment). 
 
o For example, the total estimated treatment costs12 for the 2,981 persons 
who wanted or would seek treatment for any illicit drug problem, 
ranged from $5.6 to $68.8 million, as follows: 
 
Residential                                    
 $34.4 million (residential)  
 $68.8 million (therapeutic 
community)  
 $5.6 million (in-prison 
therapeutic community) * 
 
 Outpatient 
    $7.6 million (standard 
      outpatient)  
    $16.3 million (intensive 
outpatient)  
    $12.7 million (drug court) 
 
o The estimated treatment costs for the 1,985 persons who wanted or would 
seek treatment for a stimulant-related drug problem, ranged from $3.0 
to $25.6 million, as follows: 
 
Residential                                    
 $18.7 million (residential)  
 $37.3 million (therapeutic 
community)  
                                                 
11 Aggregate unmet demand refers to gross numbers of persons needing and wanting treatment.   
Developing cost estimates for alternative levels of treatment is for illustrative purposes and provides a basic 
cost range.  These estimates are not based on specific data or assumptions about the proportions of unmet 
demand for treatment at particular levels, nor do they address the issues of determining the most 
appropriate forms of treatment to meet the unmet demand. 
12 DATCAP cost estimates are based on the study of 32 residential and 53 outpatient drug treatment 
programs between 1993 and 2002 and include and include both fixed (facility) and variable costs (See 
“DATStats:  Results from 85 studies using the Drug Abuse Treatment Cost Program Analysis,” by M.C. 
Roebuck et al, 2003).  The DATCAP data collection instrument is shown in the Appendix which also 
includes more-detailed cost and methodology information.  
*Does not include incarceration costs.  
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 $3.0 million (in-prison 
therapeutic community) * 
 
 Outpatient 
    $4.2 million (standard 
      outpatient)  
    $8.8 million (intensive 
outpatient)  
    $6.9 million (drug court) 
 
o The estimated treatment costs for the 1,359 persons who wanted or would 
seek treatment for a methamphetamine/amphetamine drug problem, 
ranged from $2.1 to $25.6 million, as follows: 
 
Residential                                    
 $12.8 million (residential)  
 $25.6 million (therapeutic 
community)  
 $2.1 million (in-prison 
therapeutic community) * 
 
 Outpatient 
    $2.9 million (standard 
      outpatient)  
    $6.0 million (intensive 
outpatient)  
    $4.7 million (drug court) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
*Does not include incarceration costs.  
*Does not include incarceration costs.  
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Table 24. 
Cost Estimates for Unmet Demand by Level of Treatment in Nebraska (2003) 
 
LEVEL OF TREATMENT/ 
PROGRAM TYPE 
(Average Duration) 
  
Average 
Cost per 
Treatment 
Episode 
18 Years 
or Older 
 
($ Millions) 
Ages  
12-17 
 
($ Millions) 
Total*  
Age 12+ 
 
($ Millions) 
Any Illicit Drug 
[Persons] 
  
[2,302] 
 
[679] 
 
[2,981] 
RESIDENTIAL     
Adult Residential 
(13 weeks) 
$9,426 $28.1 N/A N/A 
Adolescent Residential 
(8 weeks) 
$9,347 N/A $6.3 N/A 
Total Adult and Adolescent 
Residential 
   $34.4 
Therapeutic Community 
(33 weeks) 
$18,802 $56.0 $12.8 $68.8 
Therapeutic Community (Prison)** 
(28 weeks) 
$1,534 $4.6 $1.0 $5.6 
OUTPATIENT     
Standard Adult Outpatient 
(17 weeks) 
$1,944 $5.8 N/A N/A 
Standard Adolescent Outpatient 
(13 weeks) 
$2,678 N/A $1.8 N/A 
Total Adult and Adolescent 
Standard Outpatient 
   $7.6 
Intensive Outpatient 
(7 weeks) 
$4,445 $13.2 $3.0 $16.3 
Drug Court 
(46 weeks) 
$3,463 $10.3 $2.4 $12.7 
     
Stimulant-Related Drug 
[Persons] 
  
[1,533] 
 
[452] 
 
[1,985] 
RESIDENTIAL     
Adult Residential 
(13 weeks) 
$9,426 $14.4   
Adolescent Residential 
(8 weeks) 
$9,347  $4.2  
Total Adult and Adolescent 
Residential 
   $18.7 
Therapeutic Community 
(33 weeks) 
$18,802 $28.8 $8.5 $37.3 
Therapeutic Community (Prison)** 
(28 weeks) 
$1,534 $2.4 $.7 $3.0 
OUTPATIENT     
Standard Adult Outpatient 
(17 weeks) 
$1,944 $3.0   
Standard Adolescent Outpatient 
(13 weeks) 
$2,678  $1.2  
Total Adult and Adolescent 
Standard Outpatient 
   $4.2 
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Intensive Outpatient 
(7 weeks) 
$4,445 $6.8 $2.0 $8.8 
Drug Court 
(46 weeks) 
$3,463 $5.3 $1.6 $6.9 
     
Meth/Amphetamine-Related 
[Persons] 
 [1,049] [310] [1,359] 
RESIDENTIAL     
Adult Residential 
(13 weeks) 
$9,426 $9.9   
Adolescent Residential 
(8 weeks) 
$9,347  $2.9  
Total Adult and Adolescent 
Residential 
   $12.8 
Therapeutic Community 
(33 weeks) 
$18,802 $19.7 $5.8 $25.6 
Therapeutic Community (Prison)** 
(28 weeks) 
$1,534 $1.6 $.5 $2.1 
OUTPATIENT     
Standard Adult Outpatient 
(17 weeks) 
$1,944 $2.0   
Standard Adolescent Outpatient 
(13 weeks) 
$2,678  $.8  
Total Adult and Adolescent 
Standard Outpatient 
   $2.9 
Intensive Outpatient 
(7 weeks) 
$4,445 $4.7 $1.4 $6.0 
Drug Court 
(46 weeks) 
$3,463 $3.6 $1.1 $4.7 
 
* Estimates shown in 2001 dollars.  Columns may not add due to rounding.   
**Does not include incarceration costs 
 
Unmet Demand by Levels of Treatment 
 
 According to National Survey of Substance Abuse Treatment Services (N-
SSATS) data for 2003, about 85% of clients in treatment in Nebraska received 
outpatient, 14% received residential and 1% hospital inpatient.  While the proportions 
of unmet demand at each level of treatment are currently unknown, it is possible to 
illustrate alternative unmet demand cost estimates through a combination of 
residential and outpatient treatment options. 
 
Combined Residential-Outpatient Treatment Cost Illustrations 
 
• The estimated costs of providing treatment to meet the unmet demand in 
Nebraska (as shown in Table 24) are based on “stand alone” residential and 
outpatient program classifications.  Alternative programs might be developed to 
address a specific problem, such as methamphetamine addiction, through a 
combination of residential and outpatient treatment programming.   
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 (Table 25. illustrates the estimated costs three such possible combinations:  
residential-intensive outpatient, residential-standard outpatient, and residential-
drug court).13 
 
Table 25. 
Cost Estimates for Unmet Demand by 
Combined Residential and Outpatient Levels of Treatment in Nebraska (2003) 
 
COMBINED 
LEVELS OF 
TREATMENT 
OPTIONS* 
18 Years or 
Older 
 
($ Millions) 
Ages 
12-17 
 
($ Millions) 
Total**  
Age 12+ 
 
($ Millions) 
Any Illicit Drug 
[Persons] 
 
[2,302] 
 
[679] 
 
[2,981] 
Residential (50%) 
Intensive Outpatient 
(50%) 
$20.6 $4.7 $25.3 
Residential (Full)  
Standard Outpatient 
(50%) 
$31.0 $7.3 $38.2 
Residential (50%) 
 Drug Court (50%) 
$19.2 $4.4 $23.6 
Stimulant-Related 
[Persons] 
 
[1,533] 
 
[452] 
 
[1,985] 
Residential (50%) 
Intensive Outpatient 
(50%) 
$10.6 $3.1 $13.8 
Residential (Full)  
Standard Outpatient 
(50%) 
$15.9 $4.8 $20.8 
Residential (50%) 
 Drug Court (50%) 
$9.9 $2.9 $12.8 
Meth/Amphetamine-
Related [Persons] 
 
[1,049] 
 
[310] 
 
[1,359] 
Residential (50%) 
Intensive Outpatient 
(50%) 
$7.3 $2.1 $9.4 
Residential (Full)  
Standard Outpatient 
(50%) 
$10.9 $3.3 $14.2 
Residential (50%) 
 Drug Court (50%) 
$6.8 $2.0 $8.8 
 
* Residential-intensive outpatient and residential-drug court cost estimates assume 
50% reductions in both duration and costs of residential, intensive outpatient and drug 
                                                 
13 Residential-intensive outpatient and residential-drug court cost estimates assume 50% reductions in both 
duration and costs of residential, intensive outpatient and drug court programs as shown in Table 24.  
Residential-standard outpatient estimates assume full residential and 50% standard outpatient duration and 
costs.  
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court programs as shown in Table 24.  Residential-standard outpatient estimates 
assume full residential and 50% standard outpatient duration and costs. 
** Estimates shown in 2001 dollars.  Columns may not add due to rounding.   
 
 
 
 
  
 
 
 
 
 
 
 
  
 
  
 
  
 
 
        
 
